The Question Is Whether To Buy Or Not To Buy MoonLake Immunotherapeutics (NASDAQ: MLTX)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

MoonLake Immunotherapeutics is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of MoonLake Immunotherapeutics is $2.67B. A total of 0.61 million shares were traded on the day, compared to an average of 340.97K shares.

In the most recent transaction, BVF PARTNERS L P/IL sold 2,000,000 shares of MLTX for 50.00 per share on Oct 04 ’24. After the transaction, the Director now owns 1,287,768 company shares. In a previous transaction on Oct 04 ’24, Sturge Simon sold 171,000 shares at 53.72 per share. MLTX shares that Director owns now total 171,980.

Among the insiders who sold shares, Santos da Silva Jorge disposed of 56,065 shares on Feb 28 ’24 at a per-share price of $55.00. This resulted in the Chief Executive Officer holding 2,987,554 shares of MLTX after the transaction. In another insider transaction, Santos da Silva Jorge sold 4,740 shares at $55.89 per share on Feb 29 ’24. Company shares held by the Chief Executive Officer now total 2,982,814.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, MLTX has a high of $58.26 and a low of $37.55.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. MLTX’s latest balance sheet shows that the firm has $8.04M in Cash & Short Term Investments as of fiscal 2021. There were $15.00M in debt and $21.09M in liabilities at the time. Its Book Value Per Share was $7.74, while its Total Shareholder’s Equity was -$11.65M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MLTX is Buy with a score of 4.69.

Most Popular

Related Posts